reboxetine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 3 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (n-methyl-3,4-methylenedioxyamphetamine) | Trials (n-methyl-3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 4,276 | 211 | 1,392 |
| Protein | Taxonomy | reboxetine (IC50) | n-methyl-3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.9351 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.1761 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.06 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.7609 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenneisen, R; Grouzmann, E; Hoener, MC; Huwyler, J; Hysek, CM; Ineichen, M; Liechti, ME; Simmler, LD | 1 |
| Newton, TF | 1 |
| Hysek, CM; Liechti, ME | 1 |
1 review(s) available for reboxetine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Adult; Affect; Autonomic Agents; Body Temperature Regulation; Carbazoles; Carvedilol; Clonidine; Cross-Over Studies; Dopamine Uptake Inhibitors; Doxazosin; Duloxetine Hydrochloride; Female; Hemodynamics; Humans; Light; Male; Miosis; Morpholines; Mydriasis; Mydriatics; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Randomized Controlled Trials as Topic; Reaction Time; Reboxetine; Recovery of Function; Reflex, Pupillary; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Young Adult | 2012 |
1 trial(s) available for reboxetine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Hallucinogens; Heart Rate; Humans; Male; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine; Young Adult | 2011 |
1 other study(ies) available for reboxetine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
A perhaps unexpected role of norepinephrine in actions of MDMA.
Topics: Adrenergic Uptake Inhibitors; Drug Interactions; Hallucinogens; Humans; Morpholines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Reboxetine | 2011 |